BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28604451)

  • 1. Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion?
    Oz M; Korkmaz V; Meydanli MM; Sari ME; Cuylan ZF; Gungor T
    Int J Gynecol Cancer; 2017 Sep; 27(7):1393-1398. PubMed ID: 28604451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
    AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
    Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
    Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.
    Euscher E; Fox P; Bassett R; Al-Ghawi H; Ali-Fehmi R; Barbuto D; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Moschiano E; Roma A; Silva E; Malpica A
    Am J Surg Pathol; 2013 Nov; 37(11):1728-36. PubMed ID: 24061515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
    Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
    Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.
    Pelletier MP; Trinh VQ; Stephenson P; Mes-Masson AM; Samouelian V; Provencher DM; Rahimi K
    Hum Pathol; 2017 Apr; 62():33-39. PubMed ID: 27864117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.
    Sarı ME; Meydanlı MM; Yalçın I; Şahin H; Çoban G; Çelik H; Kuşçu E; Gungor T; Ayhan A
    Oncol Res Treat; 2018; 41(12):750-754. PubMed ID: 30419557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
    Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
    Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Toprak S; Sahin EA; Sahin H; Tohma YA; Yilmaz E; Meydanli MM
    Int J Gynaecol Obstet; 2021 Apr; 153(1):51-55. PubMed ID: 33118165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
    Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
    BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
    Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
    Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.
    Baiocchi G; Faloppa CC; Mantoan H; Camarço WR; Badiglian-Filho L; Kumagai LY; De Brot L; da Costa AABA
    J Surg Oncol; 2017 Aug; 116(2):220-226. PubMed ID: 28482122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myometrium Invasion, Tumour Size and Lymphovascular Invasion as a Prognostic Factor in Dissemination of Pelvic Lymphatics at Endometrial Carcinoma.
    Lucic N; Draganovic D; Sibincic S; Ecim-Zlojutro V; Milicevic S
    Med Arch; 2017 Oct; 71(5):325-329. PubMed ID: 29284899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.